Bringing A Hub-and-Spoke Business Model to Regenerative Medicine
Bioverge
00:00
Developing a Peptide-Induced De-Differentiation Therapy for Fibrosis
Learn about the innovative de-differentiation therapy being developed by SCARTEC that aims to reverse fibrosis and promote healthy regeneration. Discover the potential application of this therapy in treating pancreatic cancer.
Play episode from 26:56
Transcript
